02.12.2010 • News

EU Clears Ashland, Sud-Chemie Joint Venture

U.S. chemicals company Ashland and Sud-Chemie secured European Union regulatory approval on Tuesday to set up a joint venture in the foundry chemical sector.

The companies said in July they would merge their worldwide foundry chemical activities under the name Ask Chemicals, which will have its headquarters in Hilden, Germany. They expect to close the deal by the end of the year.
The European Commission, the EU competition watchdog, approved the joint venture and said the deal would not hamper competition in the European Economic Area (EEA).

"After examining the operation carefully, the Commission concluded that the transaction would not significantly impede effective competition in the EEA and has therefore approved the concentration," it said in a statement.

Germany's Sud-Chemie is active in speciality chemical products while U.S.-based Ashland is a manufacturer of chemical specialty and performance products as well as a distributor of chemicals and plastics.

Company

Süd-Chemie

Lenbachplatz 6
80333 München
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read